Page 1454 - Hall et al (2015) Principles of Critical Care-McGraw-Hill

Chapter 103
https://kat.cr/user/tahir99/

REFERENCES

1. Kaptein EM, Weiner JM, Robinson WJ, Wheeler WS, Nicoloff JT. 13. Scanlon MF, Weightman DR, Shale DJ, et al. Dopamine is a
Relationship of altered thyroid hormone indices to survival physiological regulator of thyrotrophin (TSH) secretion in
in nonthyroidal illnesses. Clin Endocrinol (Oxf). 1982;125: normal man. Clin Endocrinol (Oxf). January 1979;10(1):7-15.
565-574. 14. Lindenberg JA, Brehier A, Ballard PL. Triiodothyronine nuclear
2. Wartofsky L, Burman KD. Alterations in thyroid function in binding in fetal and adult rabbit lung and cultured lung cells.
patients with systemic illness: the “euthyroid sick syndrome”. Endocrinology. November 1978;103(5):1725-1731.
Endocr Rev. 1982;3:164-217. 15. Dulchavsky SA, Ksenzenko SM, Saba AA, Diebel LN.
3. Burr WA, Black EG, Griffiths RS, Hoffenber R. Serum triio- Triiodothyronine (T3) supplementation maintains sur-
dothyronine and reverse triiodothyronine concentrations after factant biochemical integrity during sepsis. J Trauma. July
surgical operation. Lancet. 1975;2:1277-1278. 1995;39(1):53-57; discussion 57-58.
4. Baue AE, Gunther B, Hartl W, Ackenheil M, Heberer G. Altered 16. Ksenzenko SM, Davidson SB, Saba AA, et al. Effect of triiodo-
hormonal activity in severely ill patients after injury or sepsis. thyronine augmentation on rat lung surfactant phospholipids
Arch Surg. 1984;119:1125-1132. during sepsis. J Appl Physiol. June 1997;82(6):2020-2027.
5. Boelen A, Kwakkel J, Fliers E. Beyond low plasma T3: local thy- 17. Raafat AM, Franko AP, Zafar R, Dulchavsky SA, Diebel
roid hormone metabolism during inflammation and infection. LN, Ksenzenko S. Effect of thyroid hormone (T3)-responsive
Endocr Rev. October 2011;32(5):670-693. changes in surfactant apoproteins on surfactant function
6. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, during sepsis. J Trauma. May 1997;42(5):803-808; discussion
Chappuis P. Selenium, systemic immune response syndrome, 808-809.
sepsis, and outcome in critically ill patients. Crit Care Med. 18. Chapital AD, Hendrick SR, Lloyd L, Pieper D. The effects of
September 1998;26(9):1536-1544. triiodothyronine augmentation on antithrombin III levels in
7. Hardy G, Hardy I, Manzanares W. Selenium supplementation in sepsis. Am Surg. March 2001;67(3):253-255; discussion 255-256.
the critically ill. Nutr Clin Pract. February 2012;27(1):21-33. 19. Brent GA, Hershman JM. Thyroxine therapy in patients with
severe nonthyroidal illnesses and low serum thyroxine concen-
8. Blake NG, Eckland JA, Foster OJF, Lightman SL. Inhibition
of hypothalamic thyrotropin-releasing hormone messenger tration. JCEM. 1986;62:1-8.
ribonucleic acid during food deprivation. Endocrinology. 20. Arem R, Karlsson F, Depe S. Intravenous levothyroxine therapy
1991;129:2714-2718. does not affect survival in severely ill intensive care unit
patients. Thyroidol Clin Exp. 1995;7:79.
9. Fliers E, Guldenaar SEF, Wiersinga WM, Swaab DF. Decreased
hypothalamic thyrotropin-releasing hormone gene expression 21. Lim VS, Henriquez C, Seo H, Refetoff S, Martino E. Thyroid
in patients with nonthyroidal illness. JCEM. 1997;82:4032-4036. function in a uremic rat model: evidence suggesting tissue
hypothyroidism. JCI. 1980;66:946-954.
10. Van den Berghe G, de Zegher F, Baxter RC, et al.
Neuroendocrinology of prolonged critical illness: effects of 22. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone
exogenous thyrotropin-releasing hormone and its combination treatment after coronary-artery bypass surgery. N Engl J Med.
with growth hormone secretagogues. J Clin Endocrinol Metab. December 7, 1995;333(23):1522-1527.
February 1998;83(2):309-319. 23. Bennett-Guerrero E, Jimenez JL, White WD, D’Amico EB,
11. Lim VS, Passo C, Murata Y, Ferrari E, Nakamura H, Refetoff S. Baldwin BI, Schwinn DA. Cardiovascular effects of intravenous
Reduced triiodothyronine content in liver but not pituitary of triiodothyronine in patients undergoing coronary artery bypass
the uremic rat model: Demonstration of changes compatible graft surgery: a randomized, double-blind, placebo- controlled
with thyroid hormone deficiency in liver only. Endocrinology. trial. Duke T3 study group. JAMA. March 6, 1996;275(9):687-692.
1984;114:280-286. 24. Blum M. Myxedema coma. Am J Med Sci. 1972;264:432-443.
12. Delatlia D. Dopamine and TSH secretion in man. Lancet. 25. Wilson WR, Bedell GN. The pulmonary abnormalities in
1977;2:760-761. myxedema. JCI. 1960;39:42-55.

Section08-O-Ref.indd 1 12/10/2014 6:08:12 PM